I think I Cydy will make money fighting Covid but it won’t be astronomical. It does do what a marketing department cannot do which is brand the company and legitimize Leronlimab. They name Cytodyn will be front and center in the medical community if we see approval in the US by year end or even EAMS in the UK.

CYtodyn will get licensing and sales agreements with other Pharma companies in place because they do not have a sales team and should not waste money now building one. It’s very expensive . So if approval comes look for licensing agreements and sales here and overseas